Skip to main content
CE

CELYSTRA Pharma

Montreal, Canada
Last funding
$14.7M
SeedMay 2026

CELYSTRA Pharma identifies, licenses, and commercializes innovative therapies for rare and underserved diseases in Canada.

Backed byInvestissement QuebecCrédit Mutuel Equity

About CELYSTRA Pharma

How much funding has CELYSTRA Pharma raised?

CELYSTRA Pharma has raised $14.7M in total funding. The most recent round was Seed. The last funding was announced in May 2026.

Who are CELYSTRA Pharma's investors?

CELYSTRA Pharma's investors include Investissement Quebec, Crédit Mutuel Equity.

Where is CELYSTRA Pharma headquartered?

CELYSTRA Pharma is headquartered in Montreal, Canada.

What does CELYSTRA Pharma do?

CELYSTRA Pharma identifies, licenses, and commercializes innovative therapies for rare and underserved diseases in Canada.

What stage is CELYSTRA Pharma at?

CELYSTRA Pharma is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"CELYSTRA Pharma — Funding & Investors." VCBacked, May 5, 2026, https://www.vcbacked.co/company/celystra-pharma. Accessed November 15, 2026.
APA
VCBacked. (2026). CELYSTRA Pharma — Funding & Investors. Retrieved November 15, 2026, from https://www.vcbacked.co/company/celystra-pharma
Wikipedia (cite web)
{{cite web |title=CELYSTRA Pharma — Funding & Investors |url=https://www.vcbacked.co/company/celystra-pharma |website=VCBacked |access-date=November 15, 2026}}

Profile data sourced and verified per the VCbacked methodology · Last funding round dated

Work at CELYSTRA Pharma? Request a listing update

Founder contacts
m***@celystrapharma.com
linkedin.com/in/●●●●●●
Emails, phones & LinkedIn · 41,000+ verified contacts
Get instant access →